Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica

Détails bibliographiques
Auteurs principaux:	Kim, B, Han, S, Kang, E, Kim, M, Min, J, Vincent, A, Waters, P, Lee, K
Format:	Conference item
Publié:	2010

Documents similaires

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
par: Min, J, et autres
Publié: (2010)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
par: Waters, P, et autres
Publié: (2008)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
par: Kim, S, et autres
Publié: (2013)

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
par: Francis, A, et autres
Publié: (2024)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
par: Waters, P, et autres
Publié: (2016)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
par: Cavus, F, et autres
Publié: (2013)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
par: Jarius, S, et autres
Publié: (2008)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
par: Sato, D, et autres
Publié: (2014)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
par: Jarius, S, et autres
Publié: (2008)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
par: Akman-Demir, G, et autres
Publié: (2011)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
par: Jarius, S, et autres
Publié: (2007)

THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER
par: Leite, M, et autres
Publié: (2012)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
par: Paul, F, et autres
Publié: (2007)

The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
par: Sato, D, et autres
Publié: (2013)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
par: Jarius, S, et autres
Publié: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
par: Jarius, S, et autres
Publié: (2008)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
par: Waters, P, et autres
Publié: (2015)

Complement activation in patients with neuromyelitis optica
par: Nytrova, P, et autres
Publié: (2014)

Complement activation in patients with neuromyelitis optica.
par: Nytrova, P, et autres
Publié: (2014)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
par: Min, J, et autres
Publié: (2013)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
par: Waters, P, et autres
Publié: (2008)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
par: Leite, M, et autres
Publié: (2009)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
par: Kitley, J, et autres
Publié: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
par: Kitley, J, et autres
Publié: (2013)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
par: Woodhall, M, et autres
Publié: (2013)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
par: Kitley, J, et autres
Publié: (2014)

Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System
par: Kim, J, et autres
Publié: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
par: Collongues, N, et autres
Publié: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
par: Kitley, J, et autres
Publié: (2012)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
par: Kitley, J, et autres
Publié: (2013)

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
par: Hacohen, Y, et autres
Publié: (2018)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
par: Saadoun, S, et autres
Publié: (2010)

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
par: Messina, S, et autres
Publié: (2021)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
par: Min, J, et autres
Publié: (2010)

The borderland of neuromyelitis optica.
par: Matthews, L, et autres
Publié: (2009)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
par: Kitley, J, et autres
Publié: (2012)

Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres
par: Waters, P, et autres
Publié: (2014)

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
par: Min, J, et autres
Publié: (2009)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
par: Palace, J, et autres
Publié: (2010)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
par: Kim, W, et autres
Publié: (2012)